Significant EBITDA Growth
Adjusted EBITDA increased from $1.8 million in the previous year to $8.2 million in the current quarter, marking an increase of more than 350%.
Improved Gross Profit Margins
Gross profit margins increased by 300 basis points compared to the same period last year.
Reduced Operating Expenses
Operating expenses were reduced by approximately $6 million compared to Q3 of 2024, and $14 million over the nine-month period.
Strong U.S. Crop Business Performance
The U.S. crop business showed strength, particularly with herbicides up about 50% and granular soil insecticides up about 5%.
Successful Cost Control Initiatives
The company reduced selling, general, and administrative expenses, and cut research and product development costs, focusing on ROI.
Positive Outlook for Free Cash Flow
Expected to generate reasonably attractive cash flow in Q4, with plans to apply this towards debt paydown.